Chemomab Therapeutics (CMMB) Interest Coverage Ratio (2018 - 2025)
Chemomab Therapeutics' (CMMB) quarterly Interest Coverage Ratio came in at 12550.0 in Q4 2025, up 47.13% YoY from 8529.74 in Q4 2024, and up 47.13% on a QoQ basis from 8529.74 in Q4 2024.
Chemomab Therapeutics (CMMB) Interest Coverage Ratio (2018 - 2025) Analysis & Trends
Chemomab Therapeutics (CMMB) has 8 years of Interest Coverage Ratio data on file, last reported at 12550.0 in Q4 2025.
- Quarterly Interest Coverage Ratio rose 47.13% year-over-year to 12550.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 20114.97 (up 135.81% YoY) and the FY2025 annual result came in at 0.82, up 19.71% from the prior year.
- Interest Coverage Ratio grew to 12550.0 in Q4 2025, from 8529.74 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 12550.0 in Q4 2025 to a low of 0.86 in Q4 2021.
- A 5-year average of 4216.58 and a median of 1.2 in 2022 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio retreated 10.16% — and 2024, when it soared 790712.57%.
- Tracing CMMB's Interest Coverage Ratio over 5 years: stood at 0.86 in 2021, then surged by 39.56% to 1.2 in 2022, then decreased by 10.16% to 1.08 in 2023, then soared by 790712.57% to 8529.74 in 2024, then soared by 47.13% to 12550.0 in 2025.
- The last three Interest Coverage Ratio figures came in at 12550.0 (Q4 2025), 8529.74 (Q4 2024), and 1.08 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | Chemomab Therapeutics | 13.33 Mn | 2.96 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12,550.00 |
| Dec 31, 2024 | 8,529.74 |
| Dec 31, 2023 | 1.08 |
| Dec 31, 2022 | 1.20 |
| Dec 31, 2021 | 0.86 |
| Dec 31, 2020 | -24.85 |
| Dec 31, 2019 | -12,689.60 |
| Sep 30, 2019 | 0.31 |
| Jun 30, 2019 | 246.83 |
| Mar 31, 2019 | 247.00 |
| Dec 31, 2018 | -3.16 |
| Sep 30, 2018 | 34.79 |
| Jun 30, 2018 | 5.16 |